Cyclogyl Generic Name & Formulations
Cyclopentolate HCl 0.5%, 1%, 2%; oph soln; contains benzalkonium chloride.
Soln 0.5%—15mL; 1%, 2%—2mL, 5mL, 15mL
To produce mydriasis and cycloplegia.
Cyclogyl Dosage and Administration
Instill 1 or 2 drops of 0.5%, 1%, or 2% in the eye; may repeat in 5–10 minutes if necessary. Apply digital pressure to lacrimal sac for 2–3 minutes after instillation to reduce systemic absorption.
Small infants: instill 1 drop of 0.5% in the eye; apply pressure over nasolacrimal sac for 2–3 minutes, observe closely for 30 minutes. Children: instill 1 or 2 drops of 0.5%, 1%, or 2% in the eye; may repeat 5–10 minutes later with 0.5% or 1% solution if necessary; apply digital pressure to lacrimal sac for 2–3 minutes after instillation to reduce systemic absorption.
Untreated narrow-angle glaucoma or when untreated anatomically narrow angles are present.
Cyclogyl Boxed Warnings
Down's syndrome. Angle-closure glaucoma. Feeding intolerance in infants; withhold feeding for 4 hours after examination. Pregnancy (Cat.C). Nursing mothers.
May interfere with antihypertensive action of carbachol, pilocarpine, ophthalmic cholinesterase inhibitors.
Cyclogyl Adverse Reactions
Ocular effects (eg, increased intraocular pressure, burning, photophobia, blurred vision, irritation, hyperemia, conjunctivitis, blepharoconjunctivitis, punctate keratitis, synechiae); CNS disturbances (esp. in children).
Cyclogyl Clinical Trials
Cyclogyl Patient Counseling